Breaking News Headlines Today

News about GLP-1

Stay current with all the latest and breaking news about GLP-1, compare headlines and perspectives between news sources on stories happening today. In total, 392 stories have been published about GLP-1 which Ground News has aggregated in the past 3 months.

Covered Most By

Anti-Aging, Acupuncture and Health News

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top GLP-1 News

Entertainment

Why Kate Winslet Finds Plastic Surgery “Terrifying”

38% Left coverage: 21 sources

Kate Winslet shared her unfiltered thoughts about the rise of plastic surgery and celebrities using weight-loss drugs: “It’s terrifying.”See the Story

GLP-1 · Cambridge

GLP-1 Receptor Agonists Likely Have Little or No Effect on Obesity-Related Cancer Risk, Research Shows

83% Left coverage: 12 sources

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.See the Story

Business

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

100% Right coverage: 1 sources

The rapid adoption of GLP-1 weight loss medications — drugs like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound and Mounjaro — is reshaping how Americans eat and shop. It's also changing how major corporations do business. From new product lines to expanding certain categories, companies are trying to capitalize on the lifestyle shifts prompted by the popular drugs."We're like at the tip of the iceberg in terms of what I think this i…GLP-1 · New York Read Article

Lilly will be 'aggressive' in spending GLP-1 money, top dealmaker Van Naarden says

ORLANDO, Fla. — Eli Lilly’s new chief dealmaker is planning to spend its GLP-1 cash in an “aggressive” but responsible manner. Last month, Lilly’s president of oncology Jacob Van Naarden wasGLP-1 · Orlando Read Article

Pfizer to pay $150M upfront for small molecule GLP-1 from Fosun subsidiary

On Nov. 19, Pfizer CFO Dave Denton said at the Jefferies Global Healthcare Conference that the large pharma was still looking for an oral small molecule for obesity and that it was ...GLP-1 · United States Read Article

The New Fever of Pregnancy: Pressure by Perfect Bodies and Its Risks – Young Pan

The era of modern emagnification medications, especially GLP-1 agonists, has led to express progress in the treatment of obesity. Reference studies, such as STEP Program and SURMOUNT-1, indicate mean reductions of 15 to 21% of body weight in 68 weeks. These figures, although clinically relevant, have ended up with unrealistic expectations in the population about the speed, magnitude and “obligatory” of pregnancy.Obesity · Brazil Read Article

GLP-1s may weaken the pelvic floor, impacting women's health –– and their sex lives

100% Left coverage: 1 sources

GLP-1 side effects like constipation and muscle mass loss can lead to uncomfortable pelvic floor symptoms like bladder leakage and painful sex.GLP-1 · United States Read Article

Glucagon-Like Peptide-1 Receptor Agonists in Osteoarthritis: From Clinical Promise to Preclinical Evidence

The post Glucagon-Like Peptide-1 Receptor Agonists in Osteoarthritis: From Clinical Promise to Preclinical Evidence appeared first on European Medical Journal.GLP-1 Read Article

Consequences of Taking Anti-Obesity Drugs without a Diet

Trying to lose weight with drugs against obesity and diabetes, GLP-1 analogues, but without diet or physical exercise, “it is a total mistake” that can have consequences, such as rebound effect or, even, severe loss of muscle mass and strength, warns Jordi Salas-Salvadó, professor of Nutrition and Bromatology of the University Rovira and Virgili of Tarragona. “I have met many people who want to lose weight without making any effort, without taki…GLP-1 · Tarragona Read Article

FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes

The US Food and Drug Administration (FDA) recently approved Novo Nordisk’s oral semaglutide, marketed as Rybelsus, to reduce the risk of major adverse cardiac events in adults with type 2 diabetes who are at high risk of these conditions.GLP-1 · United States Read Article

News about GLP-1

News about GLP-1

Covered Most By

Local News Publishers

Top GLP-1 News

Why Kate Winslet Finds Plastic Surgery “Terrifying”

GLP-1 Receptor Agonists Likely Have Little or No Effect on Obesity-Related Cancer Risk, Research Shows

Magnum Ice Cream Valued at €7.8bn in Amsterdam Listing

Blindspots

Watchdog issues safety alert for Ozempic and other GLP-1 drugs

Eli Lilly to Build $6 Billion Alabama Plant as Part of US Manufacturing Push

GLP-1 weight-loss drugs surge among women with PCOS as prescriptions soar

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Lilly will be 'aggressive' in spending GLP-1 money, top dealmaker Van Naarden says

Pfizer to pay $150M upfront for small molecule GLP-1 from Fosun subsidiary

The New Fever of Pregnancy: Pressure by Perfect Bodies and Its Risks – Young Pan

GLP-1s may weaken the pelvic floor, impacting women's health –– and their sex lives

Glucagon-Like Peptide-1 Receptor Agonists in Osteoarthritis: From Clinical Promise to Preclinical Evidence

Consequences of Taking Anti-Obesity Drugs without a Diet

FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to GLP-1

Eli Lilly to Build $6 Billion Alabama Plant as Part of US Manufacturing Push

GLP-1 weight-loss drugs surge among women with PCOS as prescriptions soar

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Lilly will be 'aggressive' in spending GLP-1 money, top dealmaker Van Naarden says

Pfizer to pay $150M upfront for small molecule GLP-1 from Fosun subsidiary

The New Fever of Pregnancy: Pressure by Perfect Bodies and Its Risks – Young Pan

GLP-1s may weaken the pelvic floor, impacting women's health –– and their sex lives

Glucagon-Like Peptide-1 Receptor Agonists in Osteoarthritis: From Clinical Promise to Preclinical Evidence

Consequences of Taking Anti-Obesity Drugs without a Diet

FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes

News about GLP-1

News about GLP-1

Covered Most By

Local News Publishers Too Big Arrow Icon

Top GLP-1 News

Why Kate Winslet Finds Plastic Surgery “Terrifying”

GLP-1 Receptor Agonists Likely Have Little or No Effect on Obesity-Related Cancer Risk, Research Shows

Magnum Ice Cream Valued at €7.8bn in Amsterdam Listing

Blindspots

Watchdog issues safety alert for Ozempic and other GLP-1 drugs

Eli Lilly to Build $6 Billion Alabama Plant as Part of US Manufacturing Push

GLP-1 weight-loss drugs surge among women with PCOS as prescriptions soar

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Lilly will be 'aggressive' in spending GLP-1 money, top dealmaker Van Naarden says

Pfizer to pay $150M upfront for small molecule GLP-1 from Fosun subsidiary

The New Fever of Pregnancy: Pressure by Perfect Bodies and Its Risks – Young Pan

GLP-1s may weaken the pelvic floor, impacting women's health –– and their sex lives

Glucagon-Like Peptide-1 Receptor Agonists in Osteoarthritis: From Clinical Promise to Preclinical Evidence

Consequences of Taking Anti-Obesity Drugs without a Diet

FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to GLP-1

Eli Lilly to Build $6 Billion Alabama Plant as Part of US Manufacturing Push

GLP-1 weight-loss drugs surge among women with PCOS as prescriptions soar

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Lilly will be 'aggressive' in spending GLP-1 money, top dealmaker Van Naarden says

Pfizer to pay $150M upfront for small molecule GLP-1 from Fosun subsidiary

The New Fever of Pregnancy: Pressure by Perfect Bodies and Its Risks – Young Pan

GLP-1s may weaken the pelvic floor, impacting women's health –– and their sex lives

Glucagon-Like Peptide-1 Receptor Agonists in Osteoarthritis: From Clinical Promise to Preclinical Evidence

Consequences of Taking Anti-Obesity Drugs without a Diet

FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes

Local News Publishers